Microglial transplantation increases amyloid‐β clearance in Alzheimer model rats
Open Access
- 16 January 2007
- journal article
- Published by Wiley in FEBS Letters
- Vol. 581 (3) , 475-478
- https://doi.org/10.1016/j.febslet.2007.01.009
Abstract
Immunization with amyloid‐β (Aβ) peptides, a therapeutic approach in Alzheimer's disease (AD), reduces brain Aβ, and microglial Aβ phagocytosis has been proposed as an Aβ‐lowering mechanism. We transplanted rat microglia into the rat lateral ventricle just after intra‐hippocampal Aβ injection, and then investigated the contribution of exogenous microglia to Aβ clearance. Migration of exogenous microglia from the lateral ventricle to Aβ plaque was detected by magnetic resonance imaging and histochemical analysis, and the clearance of Aβ was increased by transplantation. These results suggest the possible usefulness of exogenous microglia to the therapeutic approach in AD.Keywords
This publication has 26 references indexed in Scilit:
- High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicityJournal of Neuroscience Research, 2004
- Heat shock protein-90-induced microglial clearance of exogenous amyloid-β1–42 in rat hippocampus in vivoNeuroscience Letters, 2003
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's diseaseNeurochemistry International, 2001
- Lipopolysaccharide‐induced switch between retinoid receptor (RXR) α and glucocorticoid attenuated response gene (GARG)‐16 messenger RNAs in cultured rat microgliaJournal of Neuroscience Research, 2001
- Metabolic Regulation of Brain Aβ by NeprilysinScience, 2001
- Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's diseaseNature, 2000
- Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's diseaseNature, 2000
- Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer diseaseNature Medicine, 2000
- Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouseNature, 1999